C163H233Cl2F11N16O5 — CID 158176988
3-tert-butylbenzamide;1-[(4-tert-butyl-2-chlorophenyl)methyl]-4-methylpiperazine;1-[(4-tert-butyl-2-chlorophenyl)methyl]pyrrolidine;4-(4-tert-butyl-2,6-difluorophenyl)piperidine;5-(5-tert-butyl-2-methylphenyl)-1H-imidazole;3-tert-butyl-N-[(1-methylpyrrolidin-2-yl)methyl]benzamide;4-tert-butyl-1-methyl-2-(trifluoromethyl)benzene;1-(3-tert-butylphenyl)piperazin-2-one;1-(4-tert-butylphenyl)piperazin-2-one;4-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]morpholine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine (PubChem CID 158176988) has the molecular formula C163H233Cl2F11N16O5 and a molecular weight of 2776.65 g/mol. Its IUPAC name is 3-tert-butylbenzamide;1-[(4-tert-butyl-2-chlorophenyl)methyl]-4-methylpiperazine;1-[(4-tert-butyl-2-chlorophenyl)methyl]pyrrolidine;4-(4-tert-butyl-2,6-difluorophenyl)piperidine;5-(5-tert-butyl-2-methylphenyl)-1H-imidazole;3-tert-butyl-N-[(1-methylpyrrolidin-2-yl)methyl]benzamide;4-tert-butyl-1-methyl-2-(trifluoromethyl)benzene;1-(3-tert-butylphenyl)piperazin-2-one;1-(4-tert-butylphenyl)piperazin-2-one;4-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]morpholine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine.
| Compound Name | 3-tert-butylbenzamide;1-[(4-tert-butyl-2-chlorophenyl)methyl]-4-methylpiperazine;1-[(4-tert-butyl-2-chlorophenyl)methyl]pyrrolidine;4-(4-tert-butyl-2,6-difluorophenyl)piperidine;5-(5-tert-butyl-2-methylphenyl)-1H-imidazole;3-tert-butyl-N-[(1-methylpyrrolidin-2-yl)methyl]benzamide;4-tert-butyl-1-methyl-2-(trifluoromethyl)benzene;1-(3-tert-butylphenyl)piperazin-2-one;1-(4-tert-butylphenyl)piperazin-2-one;4-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]morpholine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine |
|---|---|
| PubChem CID | 158176988 |
| Molecular Formula | C163H233Cl2F11N16O5 |
| Molecular Weight | 2776.65 g/mol |
| Exact Mass | 2773.77 |
| IUPAC Name | 3-tert-butylbenzamide;1-[(4-tert-butyl-2-chlorophenyl)methyl]-4-methylpiperazine;1-[(4-tert-butyl-2-chlorophenyl)methyl]pyrrolidine;4-(4-tert-butyl-2,6-difluorophenyl)piperidine;5-(5-tert-butyl-2-methylphenyl)-1H-imidazole;3-tert-butyl-N-[(1-methylpyrrolidin-2-yl)methyl]benzamide;4-tert-butyl-1-methyl-2-(trifluoromethyl)benzene;1-(3-tert-butylphenyl)piperazin-2-one;1-(4-tert-butylphenyl)piperazin-2-one;4-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]morpholine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine |
| SMILES | CC(C)(C)c1cc(F)c(C2CCNCC2)c(F)c1.CC(C)(C)c1ccc(CN2CCCC2)c(Cl)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(N2CCNCC2=O)cc1.CC(C)(C)c1cccc(C(N)=O)c1.CC(C)(C)c1cccc(N2CCNCC2=O)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCCC1CNC(=O)c1cccc(C(C)(C)C)c1.CN1CCN(Cc2ccc(C(C)(C)C)cc2Cl)CC1.Cc1ccc(C(C)(C)C)cc1-c1cnc[nH]1.Cc1ccc(C(C)(C)C)cc1C(F)(F)F |
| InChI | InChI=1S/C19H29F3N2.C17H26N2O.C16H25ClN2.C16H22F3NO.C15H22ClN.C15H21F2N.2C14H20N2O.C14H18N2.C12H15F3.C11H15NO/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)14-8-5-7-13(11-14)16(20)18-12-15-9-6-10-19(15)4;1-16(2,3)14-6-5-13(15(17)11-14)12-19-9-7-18(4)8-10-19;1-15(2,3)13-5-4-12(14(10-13)16(17,18)19)11-20-6-8-21-9-7-20;1-15(2,3)13-7-6-12(14(16)10-13)11-17-8-4-5-9-17;1-15(2,3)11-8-12(16)14(13(17)9-11)10-4-6-18-7-5-10;1-14(2,3)11-4-6-12(7-5-11)16-9-8-15-10-13(16)17;1-14(2,3)11-5-4-6-12(9-11)16-8-7-15-10-13(16)17;1-10-5-6-11(14(2,3)4)7-12(10)13-8-15-9-16-13;1-8-5-6-9(11(2,3)4)7-10(8)12(13,14)15;1-11(2,3)9-6-4-5-8(7-9)10(12)13/h6-7,12,14H,8-11,13H2,1-5H3;5,7-8,11,15H,6,9-10,12H2,1-4H3,(H,18,20);5-6,11H,7-10,12H2,1-4H3;4-5,10H,6-9,11H2,1-3H3;6-7,10H,4-5,8-9,11H2,1-3H3;8-10,18H,4-7H2,1-3H3;4-7,15H,8-10H2,1-3H3;4-6,9,15H,7-8,10H2,1-3H3;5-9H,1-4H3,(H,15,16);5-7H,1-4H3;4-7H,1-3H3,(H2,12,13) |
| InChIKey | FYCSOWARUZPCHO-UHFFFAOYSA-N |
| XLogP | 36.44 |
| TPSA | 209.49 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 197 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2776.65 |
| LogP ≤ 5 | 36.44 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 16 |